Overview

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH

Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The main objective of this study is to evaluate efficacy and safety of (Tamsulosin) HGP0412 and HIP1402 in patients with Benign Prostatic Hyperplasia
Phase:
Phase 3
Details
Lead Sponsor:
Hanmi Pharmaceutical Company Limited
Treatments:
Tamsulosin